146 related articles for article (PubMed ID: 30007563)
1. Design, synthesis and evaluation of novel sophoridinic imine derivatives containing conjugated planar structure as potent anticancer agents.
Xu Y; Jing D; Chen R; Rashid HU; Jiang J; Liu X; Wang L; Xie P
Bioorg Med Chem; 2018 Aug; 26(14):4136-4144. PubMed ID: 30007563
[TBL] [Abstract][Full Text] [Related]
2. Novel α, β-Unsaturated Sophoridinic Derivatives: Design, Synthesis, Molecular Docking and Anti-Cancer Activities.
Xu Y; Wu L; Dai H; Gao M; Ur Rashid H; Wang H; Xie P; Liu X; Jiang J; Wang L
Molecules; 2017 Nov; 22(11):. PubMed ID: 29135958
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.
Li Z; Luo M; Cai B; Haroon-Ur-Rashid ; Huang M; Jiang J; Wang L; Wu L
Eur J Med Chem; 2018 Sep; 157():665-682. PubMed ID: 30125725
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives.
Li X; Zhao WL; Jiang JD; Ren KH; Du NN; Li YB; Wang YX; Bi CW; Shao RG; Song DQ
Bioorg Med Chem Lett; 2011 Sep; 21(18):5251-4. PubMed ID: 21807514
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors.
Zhang C; Li S; Ji L; Liu S; Li Z; Li S; Meng X
Bioorg Med Chem Lett; 2015 Oct; 25(20):4693-6. PubMed ID: 26384290
[TBL] [Abstract][Full Text] [Related]
6. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
[TBL] [Abstract][Full Text] [Related]
7. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
Huang WY; Zhang XR; Lyu L; Wang SQ; Zhang XT
Bioorg Chem; 2020 Jun; 99():103814. PubMed ID: 32278208
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Evaluation of the Matrine Derivatives as a Novel Family of Potential Anticancer Agents.
Wang J; Liu H; Zhuo XB; Ye GM; Zhao QJ
Med Chem; 2021; 17(5):493-500. PubMed ID: 31642790
[TBL] [Abstract][Full Text] [Related]
9. Novel N-substituted sophoridinol derivatives as anticancer agents.
Bi CW; Zhang CX; Li YH; Tang S; Deng HB; Zhao WL; Wang Z; Shao RG; Song DQ
Eur J Med Chem; 2014 Jun; 81():95-105. PubMed ID: 24826818
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Molecular Docking and Biological Evaluation of Quinolone Derivatives as Novel Anticancer Agents.
Li J; Zheng TC; Jin Y; Xu JG; Yu JG; Lv YW
Chem Pharm Bull (Tokyo); 2018 Jan; 66(1):55-60. PubMed ID: 29118308
[TBL] [Abstract][Full Text] [Related]
11. Molecular Design, Synthesis and Docking Study of Alkyl and Benzyl Derivatives of Robustic Acid as Topoisomerase I Inhibitors.
Chen R; Huang J; Jaiswal Y; Wei J; Huo L; Xia X; Zhong J; Williams L; Huang M; Liang Y
Chem Biodivers; 2020 Mar; 17(3):e1900556. PubMed ID: 31943759
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.
Zhang C; Qu Y; Niu B
Bioorg Med Chem; 2016 Nov; 24(22):5781-5786. PubMed ID: 27667553
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents.
Li Z; Luo M; Cai B; Wu L; Huang M; Haroon-Ur-Rashid ; Jiang J; Wang L
Bioorg Med Chem Lett; 2018 Feb; 28(4):677-683. PubMed ID: 29395978
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.
Majumdar P; Bathula C; Basu SM; Das SK; Agarwal R; Hati S; Singh A; Sen S; Das BB
Eur J Med Chem; 2015 Sep; 102():540-51. PubMed ID: 26312433
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison.
Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Atlıd Ö; Atlı Eklioğlu Ö; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1657-1673. PubMed ID: 32811204
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors.
Liu W; Zhu L; Guo W; Zhuang C; Zhang Y; Sheng C; Cheng P; Yao J; Wang W; Dong G; Wang S; Miao Z; Zhang W
Eur J Med Chem; 2011 Jun; 46(6):2408-14. PubMed ID: 21463912
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer potential of sophoridine and its derivatives: Recent progress and future perspectives.
Ur Rashid H; Rasool S; Ali Y; Khan K; Martines MAU
Bioorg Chem; 2020 Jun; 99():103863. PubMed ID: 32334197
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and docking study of new quinoline derivatives as antitumor agents.
Nasr EE; Mostafa AS; El-Sayed MAA; Massoud MAM
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800355. PubMed ID: 31081954
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.
Khadka DB; Park S; Jin Y; Han J; Kwon Y; Cho WJ
Eur J Med Chem; 2018 Jan; 143():200-215. PubMed ID: 29174815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]